In summary, AL513318.2 acts as a ceRNA network competing for binding to hsa-miR-26a-5p to regulate high expression of SLC6A8 in NSCLC and is associated with poor prognosis. Here, SLC6A8 is linked to non-small cell lung carcinoma.